Oridermyl recall in Canada: Dosage may be out of specification
In plain language
This recall involves Oridermyl ointment sold in Canada. It's being recalled because the dosage of Triamcinolone acetonide may be out of specification for certain lots. Consult your healthcare provider if you have concerns about this product.
What to do
- Stop using the product immediately.
- Check if your product's lot number is affected.
- Consult your healthcare provider before discontinuing use or for any health concerns.
- Contact Vetoquinol N.-A. Inc. if you have questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Oridermyl
Lot: 2C1103E, 2C1103G, 2C2544G
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 2C1103E, 2C1103G, 2C2544G
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves Oridermyl ointment sold in Canada. It's being recalled because the dosage of Triamcinolone acetonide may be out of specification for certain lots. Consult your healthcare provider if you have concerns about this product.
What should consumers do?
Stop using the product immediately. Check if your product's lot number is affected. Consult your healthcare provider before discontinuing use or for any health concerns. Contact Vetoquinol N.-A. Inc. if you have questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on November 28, 2024.
Is the Oridermyl brand affected by this recall?
Yes, Oridermyl products are affected by this recall. This recall involves Oridermyl ointment sold in Canada. It's being recalled because the dosage of Triamcinolone acetonide may be out of specification for certain lots. Consult your healthcare provider if you have concerns about this product.